Press Release
Categories
08
April
2022
17
March
2020
Oxehealth’s response to COVID-19
08
April
2022
03
April
2020
Oxehealth have signed a number of contracts in Q1 2020, signalling a promising year with significant growth opportunities ahead.
08
April
2022
18
September
2018
The British Standards Institute (BSI) has accredited Oxehealth’s vital signs measurement software as a Class IIa medical device in Europe.
08
April
2022
31
March
2021
Oxehealth has announced another world first after the US Food and Drug Administration granted a De Novo clearance for its Oxehealth Vital Signs product.
08
April
2022
09
March
2021
RNS Investor Release
1 / 3
